SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,071,724 | -84.8% | 52,076 | -65.4% | 0.00% | -80.0% |
Q2 2023 | $7,067,294 | +212.3% | 150,304 | +178.7% | 0.01% | +233.3% |
Q1 2023 | $2,262,735 | +3.4% | 53,926 | -6.0% | 0.00% | 0.0% |
Q4 2022 | $2,188,702 | +36378.4% | 57,386 | +40030.1% | 0.00% | – |
Q4 2021 | $6,000 | +50.0% | 143 | +70.2% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 84 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | -99.8% | 84 | -99.7% | 0.00% | -100.0% |
Q1 2021 | $2,275,000 | -83.8% | 30,399 | -81.3% | 0.00% | -70.0% |
Q4 2020 | $14,086,000 | +220.9% | 162,830 | +116.6% | 0.01% | +42.9% |
Q3 2020 | $4,390,000 | +74.3% | 75,164 | +24.1% | 0.01% | +40.0% |
Q2 2020 | $2,518,000 | +312.8% | 60,553 | +181.5% | 0.01% | +400.0% |
Q1 2020 | $610,000 | +244.6% | 21,508 | +1635.9% | 0.00% | – |
Q3 2019 | $177,000 | +15.7% | 1,239 | +48.0% | 0.00% | – |
Q2 2019 | $153,000 | -52.3% | 837 | -58.6% | 0.00% | -100.0% |
Q1 2019 | $321,000 | +26.4% | 2,020 | -23.8% | 0.00% | – |
Q4 2018 | $254,000 | -35.9% | 2,650 | -5.4% | 0.00% | -100.0% |
Q3 2018 | $396,000 | +9.7% | 2,801 | +17.9% | 0.00% | 0.0% |
Q2 2018 | $361,000 | – | 2,375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |